UCB concentrates its Nordic activities in Ørestad, Copenhagen  

Global biopharmaceutical company UCB Group has chosen to concentrate its Nordic activities in a new Nordic head office in Copenhagen's high tech enterprise zone Ørestad

UCB Nordic, which is part of the global biopharmaceutical company UCB Group based in Brussels, Belgium, has chosen to concentrate its Nordic activities in a new head office in Ørestad, Copenhagen. Invest in Denmark and Copenhagen Capacity have helped UCB in choosing the location. Invest in Denmark's benchmark tool was used to demonstrate Denmark's attractive quality-cost profile. UCB Nordic's new set-up in Ørestad will result in approx. 20 new jobs being created.

The UCB Group specialises in central nervous system disorders, allergy and respiratory diseases, immune and inflammatory disorders as well as oncology. The Group employs 8,500 people in 40 countries. In 2004, the pharma sector of UCB generated revenues of EUR 1.7 bn (USD 2 bn).

Ørestad is Copenhagen's new high tech urban enterprise zone, which is under development. It is located 1 km from the centre of the capital, near Copenhagen Airport (6 minutes by train) and the rail-road bridge linking the Danish and Swedish sides of the Øresund Region. The area lies adjacent to the motorway network and is served by Copenhagen's new metro system. Other life science companies present in Ørestad, part of Medicon Valley, include Biogen Idec Denmark, Medtronics and Ferring Pharmaceuticals.

Link > UCB Group 

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×